Successful treatment of refractory donor‐specific‐human leukocyte antigen‐antibody‐induced primary graft‐failure with daratumumab: A case report
Abstract Donor‐specific anti‐human leukocyte antigen (HLA) antibodies represent a main cause of primary graft failure specifically in the setting of haploidentical stem cell transplantation. Newer therapy strategies including daratumumab could overcome some of these limitations. We describe the case...
Shranjeno v:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2024-08-01
|
| Serija: | eJHaem |
| Teme: | |
| Online dostop: | https://doi.org/10.1002/jha2.936 |
| Oznake: |
Brez oznak, prvi označite!
|
